Purple Biotech is a publicly traded company trading on NASDAQ, led by CEO Gil Efron.
Upcoming earnings announcement for Purple Biotech
Past 12 earnings reports for Purple Biotech
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Q4 2025 | -$19.85Est: -$3.40 | -483.8% | - | — | — |
| Nov 14, 2025 | Q3 2025 | -$0.29Est: -$0.26 | -11.5% | - | — | — |
| Aug 6, 2025 | Q2 2025 | -$0.40Est: -$0.21 | -90.5% | - | — | — |
| May 21, 2025 | Q1 2025 | -$0.17 | — | — | — | — |
| Mar 10, 2025 | Q4 2024 | -$0.26Est: -$0.22 | -18.2% | - | — | — |
| Nov 15, 2024 | Q3 2024 | -$0.39Est: -$0.06 | -550.0% | - | — | — |
| Aug 16, 2024 | Q2 2024 | -$1.80Est: -$3.60 | +50.0% | - | — | — |
| May 21, 2024 | Q1 2024 | -$2.80Est: -$3.80 | +26.3% | - | — | — |
| Mar 5, 2024 | Q4 2023 | -$3.80Est: -$3.80 | 0.0% | - | — | — |
| Nov 21, 2023 | Q3 2023 | -$4.60Est: -$4.60 | 0.0% | - | — | — |
| Aug 22, 2023 | Q2 2023 | -$5.00Est: -$5.20 | +3.8% | - | — | — |
| May 16, 2023 | Q1 2023 | -$5.00Est: -$7.20 | +30.6% | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.